Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (INBX)
CUSIP: 45720N103
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 14,560,641
- Total 13F shares
- 11,165,626
- Share change
- +665,492
- Total reported value
- $171,927,470
- Put/Call ratio
- 33%
- Price per share
- $15.40
- Number of holders
- 101
- Value change
- +$10,221,839
- Number of buys
- 38
- Number of sells
- 39
Quarterly Holders Quick Answers
What is CUSIP 45720N103?
CUSIP 45720N103 identifies INBX - Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45720N103:
Top shareholders of INBX - Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
12%
|
1,787,705
|
$27,995,460 | — | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
7.3%
|
1,064,026
|
$16,662,647 | — | 30 Sep 2024 | |
| Mark P. Lappe |
3/4/5
13D/G
|
Chief Executive Officer, Director · Mark Lappe |
6.4%
from 13D/G
|
1,225,413
mixed-class rows
|
$15,852,324 | — | 12 Sep 2024 | |
| Jon Faiz Kayyem |
13D/G
|
— |
7.9%
|
1,149,046
|
$13,765,571 | $0 | 03 Jun 2024 | |
| BlackRock, Inc. |
13F
|
Company |
4.9%
|
717,153
|
$11,230,616 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
3.8%
|
549,999
|
$8,612,984 | — | 30 Sep 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
3.7%
|
536,068
|
$8,394,825 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
530,058
|
$8,300,708 | — | 30 Sep 2024 | |
| Brendan P. Eckelman |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
648,888
mixed-class rows
|
$6,127,372 | — | 29 May 2024 | |
| Slotnik Capital, LLC |
13F
|
Company |
2.5%
|
369,354
|
$5,784,084 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2%
|
289,361
|
$4,531,393 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
251,219
|
$3,934,442 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
239,240
|
$3,746,499 | — | 30 Sep 2024 | |
| Caption Management, LLC |
13F
|
Company |
1.4%
|
199,998
|
$3,131,969 | — | 30 Sep 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
166,072
|
$2,600,688 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
160,179
|
$2,508,403 | — | 30 Sep 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.1%
|
157,047
|
$2,459,356 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.99%
|
144,178
|
$2,257,827 | — | 30 Sep 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.93%
|
135,546
|
$2,122,650 | — | 30 Sep 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.84%
|
122,500
|
$1,916,000 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.78%
|
113,009
|
$1,769,721 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.76%
|
109,941
|
$1,721,676 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.68%
|
99,369
|
$1,556,119 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.67%
|
98,006
|
$1,534,774 | — | 30 Sep 2024 | |
| CSS LLC/IL |
13F
|
Company |
0.64%
|
93,125
|
$1,458,338 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.62%
|
90,647
|
$1,419,530 | — | 30 Sep 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.58%
|
84,111
|
$1,317,177 | — | 30 Sep 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.37%
|
54,092
|
$846,000 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.29%
|
42,123
|
$659,646 | — | 30 Sep 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.29%
|
41,525
|
$650,000 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.28%
|
40,871
|
$640,040 | — | 30 Sep 2024 | |
| Yakira Capital Management, Inc. |
13F
|
Company |
0.25%
|
36,195
|
$566,814 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.24%
|
35,514
|
$556,146 | — | 30 Sep 2024 | |
| Murchinson Ltd. |
13F
|
Company |
0.23%
|
33,790
|
$529,151 | — | 30 Sep 2024 | |
| Laird Norton Wetherby Wealth Management, LLC |
13F
|
Company |
0.22%
|
32,682
|
$511,801 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.22%
|
32,657
|
$511,409 | — | 30 Sep 2024 | |
| Birchview Capital, LP |
13F
|
Company |
0.22%
|
32,110
|
$502,843 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
28,231
|
$442,097 | — | 30 Sep 2024 | |
| Arbiter Partners Capital Management LLC |
13F
|
Company |
0.19%
|
28,095
|
$439,967 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
25,733
|
$402,979 | — | 30 Sep 2024 | |
| Pekin Hardy Strauss, Inc. |
13F
|
Company |
0.18%
|
25,550
|
$400,113 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.17%
|
25,100
|
$393,066 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
21,762
|
$340,793 | — | 30 Sep 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.14%
|
21,066
|
$329,894 | — | 30 Sep 2024 | |
| JBF Capital, Inc. |
13F
|
Company |
0.14%
|
20,949
|
$328,061 | — | 30 Sep 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.14%
|
20,469
|
$320,545 | — | 30 Sep 2024 | |
| BLUEFIN CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
18,475
|
$289,319 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.12%
|
17,930
|
$280,784 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.11%
|
16,055
|
$251,422 | — | 30 Sep 2024 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.09%
|
13,825
|
$216,500 | — | 30 Sep 2024 |
Institutional Holders of Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (INBX) as of Q4 2024
As of 31 Dec 2024,
Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (INBX) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,165,626 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, Sanofi, PERCEPTIVE ADVISORS LLC, BlackRock, Inc., HighTower Advisors, LLC, VANGUARD GROUP INC, Walleye Capital LLC, Sofinnova Investments, Inc., Slotnik Capital, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
101
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
95
Q4 2024 holders
101
Holder diff
6
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.